Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3742555017 | Product containing only rivastigmine in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3742556016 | Rivastigmine only product in transdermal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rivastigmine only product in transdermal dose form | Has manufactured dose form | Transdermal dose form | true | Inferred relationship | Some | ||
| Rivastigmine only product in transdermal dose form | Is a | Rivastigmine-containing product in transdermal dose form | true | Inferred relationship | Some | ||
| Rivastigmine only product in transdermal dose form | Has active ingredient | Rivastigmine | true | Inferred relationship | Some | 1 | |
| Rivastigmine only product in transdermal dose form | Is a | Rivastigmine only product | true | Inferred relationship | Some | ||
| Rivastigmine only product in transdermal dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Rivastigmine only product in transdermal dose form | Plays role | Antidementia therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rivastigmine 192 microgram/hour prolonged-release transdermal patch | Is a | True | Rivastigmine only product in transdermal dose form | Inferred relationship | Some | |
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | Is a | True | Rivastigmine only product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR